Vineet Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Vineet Laboratories Ltd. on BSE

Search Inside the pdf :

Vineet Laboratories Ltd.

14 May 2025, 06:41PM

31.10

4.75%

Company Update

Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

The Board of Directors in its meeting held on Wednesday, May 14, 2025, approved the appointment of Mr. Rajesh Kumar Kathulla (DIN: 05349717) as an additional director, designated as a Whole Time Director of the Company for a period of 3 years w.e.f May 14, 2025 to May 13, 2028, subject to the approval of the shareholders.

pdf

Vineet Laboratories Ltd.

14 May 2025, 06:33PM

31.10

4.75%

Company Update

Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of …

BSE India

The Board of Directors in its meeting held on Wednesday, May 14, 2025, has approved the increase of the Authorised Share Capital and consequent alteration of clause V of Memorandum of Association of the Company, subject to the approval of the shareholders.

pdf

Vineet Laboratories Ltd.

14 May 2025, 06:22PM

31.10

4.75%

Corp. Note

Vineet Laboratories Ltd - 543298 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

The Board of Directors of the company in its meeting held today i.e., on Wednesday, May 14, 2025 has approved the following, subject to the approval of the shareholders: 1. the appointment of Mr. Rajesh Kumar Kathulla (DIN: 05349717) as an Additional Director, designated as Whole Time Director of the Company effective May 14, 2025; 2. the increase of Authorised Share Capital from the existing ?.10,81,00,000/- (Rupees Ten Crore Eighty one Lakh Only) consisting of 1,08,10,000 (One Crore Eight Lakh Ten Thousand Only) equity shares of face value ?.10.00/- each to ? 20,00,00,000/- (Rupees Twenty Crore Only) consisting of 2,00,00,000 (Two Crore Only) equity shares of face value ?.10.00/- each, and the consequent alteration of Clause V of the Memorandum of Association of the Company.

pdf

Vineet Laboratories Ltd.

14 May 2025, 05:10PM

31.10

4.75%

Company Update

Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We are hereby submitting the newspaper advertisement in Financial Express (English language) and Nava Telangana (Telugu Language) regarding the Audited standalone financial results of the Company for the fourth quarter and the financial year ended on 31st March, 2025 and the audited standalone financial statements for the financial year ended on 31st March, 2025.

pdf

Vineet Laboratories Ltd.

12 May 2025

31.10

4.75%

Company Update

Vineet Laboratories Ltd - 543298 - Announcement Under Regulation 30 Of SEBI (LODR) - Appointment Of …

BSE India

The Board of Directors of the Company in its meeting held today on Monday, May 12, 2025 has recommended the appointment of M/s. P S Rao & Associates, Company Secretaries as the Secretarial Auditors of the Company for a period of 5 consecutive years for the approval of the Shareholders at the ensuing Annual General Meeting.

pdf

Vineet Laboratories Ltd.

12 May 2025

31.10

4.75%

Company Update

Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

The Board of Directors in its meeting held today on Monday, May 12, 2025 has approved the re-appointment of Mr. Dilip Vishnu Achrekar (DIN:08849689) as an Independent Director of the Company, subject to the approval of shareholders.

pdf

Vineet Laboratories Ltd.

12 May 2025

31.10

4.75%

Result

Vineet Laboratories Ltd - 543298 - Audited Standalone Financial Results Of The Company For The Fourth …

BSE India

The Board of Directors in its meeting held today on Monday, May 12, 2025 have approved the Audited Financial Statements for the Quarter and Financial year ended on March 31, 2025

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	15.46	18.13	37.46	-14.7%	-58.7%
Operating Profit Qtr	-11.05	-4.14	3.42	-166.9%	-423.1%
Net Profit Qtr	-10.53	-5.71	1.92	-84.4%	-648.4%
Earning Per Share Adjusted latest Qtr	-11.42	-6.19	2.09	-84.5%	-646.4%

* Standalone data

Detailed Results

Vineet Laboratories Ltd.

12 May 2025

31.10

4.75%

Board Meeting

Vineet Laboratories Ltd - 543298 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

The Board of Directors of the company in its meeting held today i.e., on May 12, 2025 has : approved the Audited Standalone Financial Results of the company for the fourth quarter and the financial year ended on 31st March 2025 and the Audited Standalone Financial Statement for the financial year ended on 31st March 2025 along with Audit Report. approved the re-appointment of Mr. Dilip Vishnu Acharekar (DIN: 08849689) as an independent director of the Company. recommended the appointment of M/s. P S Rao & Associates, Company Secretaries as the Secretarial Auditor of the Company for a period of 5 consecutive years for the approval of the shareholders at the ensuing Annual General Meeting.

pdf

Vineet Laboratories Ltd.

06 May 2025

31.10

4.75%

Board Meeting

Vineet Laboratories Ltd - 543298 - Board Meeting Intimation for Considering The Audited Standalone Results

BSE India

Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 ,inter alia, to consider and approve the Audited Standalone Financial Results of the Company for the Fourth Quarter and the Financial Year ended on March 31, 2025.

pdf

Vineet Laboratories Ltd.

17 Apr 2025

31.10

4.75%

Corp. Note

Vineet Laboratories Ltd - 543298 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyVineet Laboratories Ltd 2CIN NO.L24304TG2016PLC112888 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 39.07 4Highest Credit Rating during the previous FY - 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Ramesh Kumar Bandari Designation: Company Secretary cum Compliance Officer EmailId: cs@vineetlabs.co.in Name of the Chief Financial Officer: Satyanarayana Raju Bhupathiraju Designation: Whole time director cum CFO EmailId: bhsnraju6969@gmail.com Date: 17/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

VOTE: Is Vineet Laboratories Ltd. worth buying?

18 Votes:

Buy 88.89%

Sell 5.56%

Hold 5.56%